Web Content Management
PRODUCTS
-
Drug safety is too important to entrust to underqualified teams or unpredictable models.
-
IntegriCell™ cryopreservation services from Cryoport Systems optimize leukapheresis-derived cell therapies by enhancing the safety, quality, and viability of manufacture-ready cryopreserved leukopaks. Our state-of-the-art cryopreservation process, integrated with our end-to-end global temperature-controlled supply chain platform, provides unmatched reliability, efficiency, and scope. Our standardized protocols meet the highest compliance standards, ensuring consistent quality and addressing product stability issues associated with fresh donor-derived cellular material for an optimized approach that enhances manufacturing efficiency and streamlines operations.
-
This easy-to-use process analytical technology device offers in-line bioprocess analysis and control with no complex modeling. Measure multiple critical parameters across media, across processes, across mammalian cell lines, across scales.
All In-line Gain, No Modeling Pain
MAVERICK is powered by Raman spectroscopy and a purpose-built de novo model. The de novo model is explicitly built on media chemistries and device physics, not on empirical data. It automatically interprets the spectra and quantifies process parameters enabling simultaneous measurements of glucose, lactate, and total biomass. This is achieved without the costs, complexities, and risks associated with conventional Process Analytical Technology (PAT) methods. There is no need to grapple with complex empirical models, reagents, or unreliable auto-sampling systems to implement in-line bioprocess analysis.
-
Evolve from paper to life sciences digital operations quickly and simply, paving the fastest path to fewer deviations and faster batch releases with data-driven manufacturing.
-
Planning to launch a patient-centric decentralized clinical trial? Give your clinical trial patients an app that makes it easy to participate—from anywhere at any time.
WHITE PAPERS AND CASE STUDIES
-
How To Unlock The Secret To Repeatable, Scalable Low Turnover
Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.
-
Understanding Biosafety Levels
Compliance with biosafety levels (BSLs) is crucial in ensuring that your laboratories meet stringent standards to protect staff and prevent the escape of biological agents.
-
MilliporeSigma's 97-Day Implementation Success Story
Read how MilliporeSigma transformed validation processes with a digital validation system to achieve compliance in just 97 days, as well as learn key takeaways from their swift transition.
-
Improving Manufacturing Data Collection And Information Visibility
A top global CDMO facing challenges with communicating manufacturing data and making informed decisions implemented a digital solution that improved data collection and information visibility.
-
Preparing The Next Generation Of Clinical Research Professionals
Explore the live EDC platform that enabled Durham Tech to create a model for future-forward, hands-on education in clinical research.
-
Revolutionizing European Football With UWB Micro-Location
See how UWB micro-location technology was utilized by European League Football to address pandemic-era challenges, but quickly transformed into a vital tool for player analytics and safety monitoring.
-
Custom Orthodontic Aligner Manufacturer Ensures Compliance With Tulip
A pioneering orthodontic startup is transforming custom aligner production using 3D printing and software to cut time and costs in half while scaling rapidly to ensure quality and compliance.
-
Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.
-
The Evolution Of Clinical Operations And The Growth Of FSP Partnerships
Explore the integration of new technologies, the FSP’s role in promoting patient diversity, and how clinical operations leaders are increasingly becoming thought leaders within the industry.
-
PFAS Removal System Proven Effective In Removing Both Long And Short Chain PFAS
A new system removed all nine PFAS compounds from a municipality's water to non-detect levels in a single pass. Unlike traditional methods, it addresses both long- and short-chain PFAS while generating minimal waste.
-
Evansville Water & Sewer Utility: 4 Tactics For Managing & Organizing Vertical Assets
EWSU, serving 65,000 customers, revamped its vertical asset tracking with POWER Engineers to enhance maintenance workflows. Here's how they optimized their processes.
-
Life Sciences Corporation Implements eLogbooks Across 15 Sites
New regulations challenged how surgical kits were tracked and processed across 15 U.S. sites. Discover how one team balanced compliance and efficiency to keep life-saving procedures on schedule.
NEWS
-
Memorial Hospital Selects CareCloud's HealthLine To Drive Supply Chain Efficiency And Inventory Integrity1/29/2026
CareCloud, Inc. (Nasdaq: CCLD, CCLDO) ("CareCloud" or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced the signing of Memorial Hospital in Marysville, Ohio for its HealthLine supply chain management platform.
-
BIoNTX And The Cleanroom Center Launch Strategic Hub For Drug Manufacturing In Dallas7/28/2025
The Cleanroom Center has launched its global headquarters in Dallas, partnering with BioNTX to help life science and advanced manufacturing companies accelerate cleanroom selection and deployment
-
Quidelortho And Bühlmann Laboratories AG Announce Availability Of Fecal Calprotectin (fCAL®) Turbo And Fecal Pancreatic Elastase (fPELA®) Turbo Assays On Vitros™ Systems As A Microtip™ Partnership Assay (Mpa)7/14/2025
QuidelOrtho Corporation ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo assays on QuidelOrtho's VITROS Systems as an MPA.
-
Oasis Diagnostics And Oludent Health Announce Major Strategic Partnership To Expand Saliva-Based Diagnostics11/24/2025
Oasis Diagnostics Corporation (USA), a global leader in non-invasive saliva collection and testing technologies, and Oludent Health International FZC (UAE), a fast-growing molecular diagnostics and telehealth provider, today announced a strategic project partnership designed to bring scalable, accessible diagnostic solutions to emerging markets across Africa, the Middle East, and Southeast Asia.
-
BioLargo Reports Annual 2025 Operating And Financial Results3/11/2026
BioLargo closed 2025 with $3.9 M cash, advanced commercialization across multiple business segments, and grew engineering services revenue 98%, setting the stage for new 2026 opportunities.